Science Explorer Back to mapMap
Discussion
Researcher · Mie University · Japan

Liqing Zang

Liqing Zang publishes mostly in Molecular Biology, Cell Biology and Epidemiology, on topics such as Zebrafish Biomedical Research Applications, Adipokines, Inflammation, and Metabolic Diseases and Adipose Tissue and Metabolism.

ORCID 0000-0001-6936-795X OpenAlex
World rank
#1,695,996
of 7,710,434 ranked researchers
Rank in Japan
#28,578
of 383,136
Works
75
Citations
2.8k
Citations per work
37.1
h-index
24
i10-index 41Top 24% in Molecular Biology
Liqing Zang

What does Liqing Zang research?

Liqing Zang's work is mostly in Biochemistry, Genetics and Molecular Biology (31%), Medicine (20%), Immunology and Microbiology (5%).

Everything else: 33 works · 44.1% of their workLife Sciences: 27 works · 35.5% of their workBiochemistry, Genetics and Molecular Biology: 23 works · 30.6% of their workMolecular Biology: 12 works · 16.0% of their workCell Biology: 11 works · 14.6% of their workImmunology and Microbiology: 4 works · 4.9% of their workImmunology: 4 works · 4.9% of their workHealth Sciences: 15 works · 20.4% of their workMedicine: 15 works · 20.4% of their workEpidemiology: 5 works · 7.3% of their workPhysiology: 5 works · 7.3% of their workSurgery: 4 works · 5.8% of their workTHEIR WORKLiqing Zang75works
Life Sciences36%Health Sciences20%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else3344.1%
    1. Biochemistry, Genetics and Molecular Biology2330.6%
    2. Immunology and Microbiology44.9%
    1. Medicine1520.4%
  1. 1Molecular Biology16% of their works
  2. 2Cell Biology15% of their works
  3. 3Epidemiology7% of their works
  4. 4Physiology7% of their works
  5. 5Surgery6% of their works
  6. 6Immunology5% of their works

Research topics

Which keywords describe Liqing Zang's research?

The keywords of their largest research topics: Drug Discovery, Model Organism, Zebrafish, Insulin Resistance, Cardiovascular Disease, Inflammation, Adipose Tissue and Brown Adipose Tissue.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Drug Discovery292 topics
  2. Model Organism251 topic
  3. Zebrafish251 topic
  4. Insulin Resistance242 topics
  5. Cardiovascular Disease172 topics
  6. Inflammation172 topics
  7. Adipose Tissue121 topic
  8. Brown Adipose Tissue121 topic
  9. Obesity121 topic
  10. Thermogenesis121 topic
  11. Pancreatic Islets71 topic
  12. ß-Cell Dysfunction71 topic
  13. Dietary Intake51 topic
  14. Gut Microbiota51 topic
  15. Microbial Communities51 topic
  16. Omega-3 Fatty Acids51 topic
  17. Bioactive Compounds41 topic
  18. Crystal Structure41 topic
  19. G-Protein-Coupled Receptors41 topic
  20. Seaweed41 topic

Where does Liqing Zang work?

Liqing Zang's main affiliation in the publication record is Mie University, Japan.

How many publications and citations does Liqing Zang have?

OpenAlex counts 75 works and 2,783 citations for Liqing Zang, an h-index of 24, ranking #1,695,996 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Liqing Zang. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.